Deeptech Funding News Robotics

India’s Morphle Labs Raises $5 Mn Series A To Expand Globally

• ByStartupStory     |    November 27, 2025

Deep-Tech Startup Automates Cancer Diagnostics With Robotics And AI

Bengaluru-based deep-tech pathology startup Morphle Labs has raised $5 million (₹44.6 Cr) in a Series A funding round led by Inflexor Ventures. The capital will accelerate global market expansion, scale manufacturing for flagship products RoboTome and MorphoLens, secure international regulatory approvals, and strengthen its IP portfolio with over 80 patents filed in robotics, embedded systems, and medical imaging.​

Revolutionizing Histopathology Workflows

Founded in 2017 by Rohit Hiwale (CEO), Ashish Manmode (CTO), and Sunnel Daniel (COO), Morphle combines robotics, precision hardware, optics, and AI computer vision to automate core cancer diagnostic processes like tissue slicing and slide imaging. RoboTome precisely slices biopsy blocks at twice the speed of expert histotechnologists, while MorphoLens digitizes over 100 slides per hour, addressing labor-intensive bottlenecks in anatomic pathology that remain undigitized unlike radiology or hematology.​

The 100-member team across Bengaluru and Boston has deployed solutions in 30+ countries, targeting labs and hospital networks with physical AI platforms for high-throughput, accurate diagnostics.​

Scaling For Global Commercialization

Proceeds prioritize 10x capacity growth, hiring in robotics, vision systems, optics, hardware, and medical-grade software, plus regulatory push in key markets. Inflexor Ventures’ Pratip Mazumdar called Morphle a “must-have” platform solving critical healthcare gaps through integrated robotics and AI, positioning it as an India-for-the-world story across diagnostics segments​

CEO Hiwale highlighted unprecedented demand for RoboTome’s novel automation in tissue prognostics, entering full go-to-market amid rising cancer caseloads and diagnostic backlogs globally. This raise fuels Morphle’s transformation of histopathology into scalable, precision workflows.

Follow Startup Story